How many shares of XENE does CITADEL ADVISORS LLC own?

As of 2026-Q2, CITADEL ADVISORS LLC holds 1.4M shares of XENE (XENON PHARMACEUTICALS INC).

What is CITADEL ADVISORS LLC's XENE position worth?

As of 2026-Q2, CITADEL ADVISORS LLC's XENE position is worth $84.6M.

In 2026-Q2, CITADEL ADVISORS LLC decreased their XENE position (-47.2% change in shares).

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in XENE in 2018-Q4. They have held the position across 31 quarters.

Position history for CITADEL ADVISORS LLC's holdings in XENON PHARMACEUTICALS INC

Current Value

$84.6M

Current Shares

1.4M

Total Value Change

+$79.3M

Total Shares Change

+562,940

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.4M	-47.2%	$84.6M	0.0%	$60.36	0
2026-Q1	Increased	2.7M	+100.8%	$154.3M	0.0%	$43.79	49
2025-Q4	Increased	1.3M	+37.8%	$59.2M	0.0%	$44.12	39
2025-Q3	Increased	959,098	+699.0%	$38.5M	0.0%	$39.06	47
2025-Q2	Decreased	120,045	-82.5%	$3.8M	0.0%	$32.40	0
2025-Q1	Increased	687,088	+109.9%	$23.1M	0.0%	$34.26	46
2024-Q4	Decreased	327,303	-54.7%	$12.8M	0.0%	$38.53	0
2024-Q3	Decreased	722,504	-6.0%	$28.4M	0.0%	$38.65	0
2024-Q2	Decreased	768,726	-40.3%	$30M	0.0%	$38.99	0
2024-Q1	Increased	1.3M	+1.6%	$55.4M	0.0%	$43.05	30
2023-Q4	Increased	1.3M	+75.1%	$58.4M	0.0%	$46.06	44
2023-Q3	Increased	723,524	+44.4%	$24.7M	0.0%	$34.16	39
2023-Q2	Decreased	501,012	-42.5%	$19.3M	0.0%	$38.43	0
2023-Q1	Decreased	871,234	-25.2%	$31.2M	0.0%	$35.61	0
2022-Q4	Increased	1.2M	+2.0%	$45.9M	0.0%	$39.43	30
2022-Q3	Decreased	1.1M	-30.7%	$41.2M	0.0%	$35.89	0
2022-Q2	Increased	1.6M	+14.4%	$50.1M	0.0%	$30.90	33
2022-Q1	Increased	1.4M	+11.9%	$44.1M	0.0%	$30.12	33
2021-Q4	Increased	1.3M	+53.1%	$40.2M	0.0%	$31.99	41
2021-Q3	Decreased	841,216	-19.4%	$12.9M	0.0%	$14.86	0
2021-Q2	Increased	1M	+368.9%	$19.4M	0.0%	$18.05	46
2021-Q1	Increased	222,552	+211.0%	$4M	0.0%	$17.49	43
2020-Q4	Decreased	71,550	-77.0%	$1.1M	0.0%	$16.04	0
2020-Q3	Decreased	311,682	-20.1%	$3.5M	0.0%	$10.83	0
2020-Q2	Decreased	390,260	-22.9%	$4.9M	0.0%	$12.01	0
2020-Q1	Increased	506,029	+117.9%	$5.7M	0.0%	$10.96	44
2019-Q4	Decreased	232,265	-14.6%	$3M	0.0%	$13.20	0
2019-Q3	Decreased	272,085	-37.8%	$2.5M	0.0%	$8.77	0
2019-Q2	Decreased	437,580	-32.9%	$4.3M	0.0%	$9.86	0
2019-Q1	Decreased	652,023	-22.2%	$6.6M	0.0%	$10.16	0
2018-Q4	New	838,302	-	$5.3M	0.0%	$5.92	37

Other major holders of XENE: FMR LLC, BlackRock, Inc.